56 Veletri® and Flolan® (Epoprostenol Sodium) in the Treatment of Pulmonary Arterial Hypertension von Chin, K.M, Badesch, D.B, Robbins, I.M, Tapson, V.F, Palevsky, H, Kim, N.H, Kawut, S.M, Frost, A, Benton, W.W, Lemarie, J.C, Bodin, F, Rubin, L.J, McLaughlin, V.V

Volltext

Long-Term Safety and Tolerability of a New Formulation of Epoprostenol in Pulmonary Arterial Hypertension (PAH) Patients: Final Results from EPITOME-2 von Granton, J, Bergot, E, Boonstra, A, Subias, P.E, Galiè, N, Langleben, D, Lemarié, J.C, Pfister, T, Simonneau, G, Sitbon, O, Delcroix, M

Volltext

PRO1 MEDICAL THERAPY FOR PULMONARY ARTERIAL HYPERTENSION (PAH): AN INDIRECT TREATMENT COMPARISON OF MACITENTAN AND BOSENTAN von Di Scala, L., Perchenet, L., Lemarié, J.C.

Volltext

On the stability and accuracy of the harmonic and biharmonic isoneutral mixing operators in ocean models von Lemarié, F., Debreu, L., Shchepetkin, A.F., McWilliams, J.C.

Volltext

HFA inhalers von Koninck, J.C., Magro, P., Khanjari, F., Lemarié, E., Diot, P.

Volltext

Influence of imuthiol on pituitary hormone levels in man von Renoux, G., Lemarié, E., Besnard, J.C., Renoux, M.

Volltext